FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3156651285> ?p ?o ?g. }

• W3156651285 abstract "Natural killer (NK) cell therapy has proven to be a promising approach for the treatment of malignancies. Osaki method for ex-vivo autologous NK cell expansion has been recently introduced in Japan. To start clinical trial phase I at Shiraz University of Medical Sciences in collaboration with the Japanese group, this preclinical setting study aimed to evaluate the proliferative efficacy of the method, the activation status of expanded autologous NK cells, and the likely unwanted contamination of the final cell product. Peripheral blood mononuclear cells (PBMCs) were isolated from 5 healthy individuals' peripheral blood and transferred directly to the specified initial culture bag containing anti-CD52 and anti-CD3 and Interleukin (IL)-2. The cells were cultured for 14-17 days in an incubator, during which the cells received condition media, and underwent several passages into bigger culture bags. All the procedures were carried out in a cleanroom and associated facilities. Before and after activation PBMCs were analyzed for their phenotype and cytotoxic activity; using flow cytometry and cytokine release assay. Our results indicated that NK (CD3-CD16+/-CD56+) cells were expanded 510-fold on average (range 200-1100 fold), and the purity of NK cells per whole lymphocytes exceeded 68%. The expanded cells were highly lytic as indicated by in-vitro cytotoxic assay, with a strong expression of Natural killer group 2 member D (NKG2D) and CD16. The prepared final cell products were negative for HCV, HBV, HIV, mycoplasma, and endotoxin. In the preclinical phase, large numbers of activated and un-contaminated NK cells from healthy individuals' peripheral blood were successfully generated. The method seems to provide ample clean cell product with no contamination and has the potential to be used for NK cell therapy in future clinical trials, suitable to be infused back to the donors in phase I clinical trial." @default.
• W3156651285 created "2021-04-26" @default.
• W3156651285 creator A5005767524 @default.
• W3156651285 creator A5012306452 @default.
• W3156651285 creator A5022547588 @default.
• W3156651285 creator A5067149839 @default.
• W3156651285 creator A5067420983 @default.
• W3156651285 creator A5076042166 @default.
• W3156651285 date "2021-04-19" @default.
• W3156651285 modified "2023-09-26" @default.
• W3156651285 title "Autologous Natural Killer Cell-enrichment for Immune Cell Therapy: Preclinical Setting Phase, Shiraz Experience" @default.
• W3156651285 cites W1634951127 @default.
• W3156651285 cites W1828402880 @default.
• W3156651285 cites W1966426962 @default.
• W3156651285 cites W2021377837 @default.
• W3156651285 cites W2027470770 @default.
• W3156651285 cites W2064981157 @default.
• W3156651285 cites W2092215629 @default.
• W3156651285 cites W2113811237 @default.
• W3156651285 cites W2125336347 @default.
• W3156651285 cites W2158513713 @default.
• W3156651285 cites W2170944606 @default.
• W3156651285 cites W2272769504 @default.
• W3156651285 cites W2613052561 @default.
• W3156651285 cites W2751221763 @default.
• W3156651285 cites W2766512176 @default.
• W3156651285 cites W2788975023 @default.
• W3156651285 cites W2793215815 @default.
• W3156651285 cites W2955397772 @default.
• W3156651285 doi "https://doi.org/10.18502/ijaai.v20i2.6056" @default.
• W3156651285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33904681" @default.
• W3156651285 hasPublicationYear "2021" @default.
• W3156651285 type Work @default.
• W3156651285 sameAs 3156651285 @default.
• W3156651285 citedByCount "1" @default.
• W3156651285 countsByYear W31566512852023 @default.
• W3156651285 crossrefType "journal-article" @default.
• W3156651285 hasAuthorship W3156651285A5005767524 @default.
• W3156651285 hasAuthorship W3156651285A5012306452 @default.
• W3156651285 hasAuthorship W3156651285A5022547588 @default.
• W3156651285 hasAuthorship W3156651285A5067149839 @default.
• W3156651285 hasAuthorship W3156651285A5067420983 @default.
• W3156651285 hasAuthorship W3156651285A5076042166 @default.
• W3156651285 hasBestOaLocation W31566512851 @default.
• W3156651285 hasConcept C114684123 @default.
• W3156651285 hasConcept C137061746 @default.
• W3156651285 hasConcept C154317977 @default.
• W3156651285 hasConcept C167672396 @default.
• W3156651285 hasConcept C202751555 @default.
• W3156651285 hasConcept C203014093 @default.
• W3156651285 hasConcept C2778102761 @default.
• W3156651285 hasConcept C2778867473 @default.
• W3156651285 hasConcept C2781462264 @default.
• W3156651285 hasConcept C55493867 @default.
• W3156651285 hasConcept C71924100 @default.
• W3156651285 hasConcept C86803240 @default.
• W3156651285 hasConcept C8891405 @default.
• W3156651285 hasConceptScore W3156651285C114684123 @default.
• W3156651285 hasConceptScore W3156651285C137061746 @default.
• W3156651285 hasConceptScore W3156651285C154317977 @default.
• W3156651285 hasConceptScore W3156651285C167672396 @default.
• W3156651285 hasConceptScore W3156651285C202751555 @default.
• W3156651285 hasConceptScore W3156651285C203014093 @default.
• W3156651285 hasConceptScore W3156651285C2778102761 @default.
• W3156651285 hasConceptScore W3156651285C2778867473 @default.
• W3156651285 hasConceptScore W3156651285C2781462264 @default.
• W3156651285 hasConceptScore W3156651285C55493867 @default.
• W3156651285 hasConceptScore W3156651285C71924100 @default.
• W3156651285 hasConceptScore W3156651285C86803240 @default.
• W3156651285 hasConceptScore W3156651285C8891405 @default.
• W3156651285 hasLocation W31566512851 @default.
• W3156651285 hasOpenAccess W3156651285 @default.
• W3156651285 hasPrimaryLocation W31566512851 @default.
• W3156651285 hasRelatedWork W134790080 @default.
• W3156651285 hasRelatedWork W1965279001 @default.
• W3156651285 hasRelatedWork W2018916009 @default.
• W3156651285 hasRelatedWork W2043121522 @default.
• W3156651285 hasRelatedWork W2160294652 @default.
• W3156651285 hasRelatedWork W2389848379 @default.
• W3156651285 hasRelatedWork W2549381813 @default.
• W3156651285 hasRelatedWork W3093558663 @default.
• W3156651285 hasRelatedWork W3141671192 @default.
• W3156651285 hasRelatedWork W4200291903 @default.
• W3156651285 isParatext "false" @default.
• W3156651285 isRetracted "false" @default.
• W3156651285 magId "3156651285" @default.
• W3156651285 workType "article" @default.